D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 72 Citations 22,304 151 World Ranking 16212 National Ranking 8253

Overview

What is he best known for?

The fields of study Thomas Force is best known for:

  • Signal transduction
  • Kinase
  • p38 mitogen-activated protein kinases

Thomas Force merges Kinase with MAPK/ERK pathway in his research. With his scientific publications, his incorporates both MAPK/ERK pathway and Kinase. His work on Cell biology is being expanded to include thematically relevant topics such as Protein kinase A. Thomas Force regularly links together related areas like Biochemistry in his Protein kinase A studies. Thomas Force incorporates Biochemistry and Molecular biology in his studies. While working in this field, Thomas Force studies both Molecular biology and Cell biology. Computer network is closely attributed to Terminal (telecommunication) in his research. His Terminal (telecommunication) study frequently links to other fields, such as Computer network. Thomas Force merges p38 mitogen-activated protein kinases with Mitogen-activated protein kinase in his study.

His most cited work include:

  • The stress-activated protein kinases are major c-Jun amino-terminal kinases activated by ischemia and reperfusion (241 citations)
  • Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy. (191 citations)

What are the main themes of his work throughout his whole career to date

His Internal medicine study frequently draws parallels with other fields, such as Contraction (grammar). He regularly ties together related areas like Internal medicine in his Contraction (grammar) studies. His studies link Angiotensin II with Biochemistry. His research links Receptor with Angiotensin II. Many of his studies involve connections with topics such as Endothelin 1 and Receptor. Cell biology and Mitogen-activated protein kinase kinase are frequently intertwined in his study. Mitogen-activated protein kinase kinase and Cyclin-dependent kinase 9 are commonly linked in his work. In his works, he undertakes multidisciplinary study on Cyclin-dependent kinase 9 and Cyclin-dependent kinase 2. His research on Cyclin-dependent kinase 2 frequently links to adjacent areas such as Protein kinase A.

Thomas Force most often published in these fields:

  • Internal medicine (66.67%)
  • Biochemistry (58.33%)
  • Cell biology (41.67%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate

Risto Kerkelä;Luanda Grazette;Rinat Yacobi;Cezar Iliescu.
Nature Medicine (2006)

1313 Citations

Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Juan Carlos Plana;Maurizio Galderisi;Ana Barac;Michael S. Ewer.
Journal of The American Society of Echocardiography (2014)

1291 Citations

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

Tammy F Chu;Tammy F Chu;Maria A Rupnick;Maria A Rupnick;Risto Kerkela;Susan M Dallabrida.
The Lancet (2007)

1126 Citations

Heart failure: preventing disease and death worldwide.

Piotr P. Ponikowski;Stefan D. Anker;Khalid F. AlHabib;Martin R. Cowie.
Esc Heart Failure (2014)

1030 Citations

Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium

A B Abou-Samra;H Jüppner;T Force;M W Freeman.
Proceedings of the National Academy of Sciences of the United States of America (1992)

976 Citations

Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition.

Thomas Force;Daniela S. Krause;Richard A. Van Etten.
Nature Reviews Cancer (2007)

867 Citations

Akt Activation Preserves Cardiac Function and Prevents Injury After Transient Cardiac Ischemia In Vivo

Takashi Matsui;Jingzang Tao;Federica del Monte;Kyung-Han Lee.
Circulation (2001)

804 Citations

Protein kinase cascades in the regulation of cardiac hypertrophy

Gerald W. Dorn;Thomas Force.
Journal of Clinical Investigation (2005)

798 Citations

Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Beth A. Rose;Thomas Force;Yibin Wang.
Physiological Reviews (2010)

708 Citations

Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy

Syed Haq;Gabriel Choukroun;Zhao Bin Kang;Hardeep Ranu.
Journal of Cell Biology (2000)

514 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Thomas Force

Jeffery D. Molkentin

Jeffery D. Molkentin

Cincinnati Children's Hospital Medical Center

Publications: 114

Harald Jüppner

Harald Jüppner

Harvard University

Publications: 54

Javid Moslehi

Javid Moslehi

University of California, San Francisco

Publications: 51

James R. Woodgett

James R. Woodgett

Lunenfeld-Tanenbaum Research Institute

Publications: 47

Anthony Rosenzweig

Anthony Rosenzweig

Harvard University

Publications: 42

Patrizio Lancellotti

Patrizio Lancellotti

University of Liège

Publications: 40

Stephan von Haehling

Stephan von Haehling

University of Göttingen

Publications: 40

Walter J. Koch

Walter J. Koch

Temple University

Publications: 39

Alexander R. Lyon

Alexander R. Lyon

National Institutes of Health

Publications: 38

Gino V. Segre

Gino V. Segre

Harvard University

Publications: 38

Jong-Sup Bae

Jong-Sup Bae

Kyungpook National University

Publications: 38

Joseph V. Bonventre

Joseph V. Bonventre

Brigham and Women's Hospital

Publications: 37

Thomas H. Marwick

Thomas H. Marwick

Baker IDI Heart and Diabetes Institute

Publications: 37

David Goltzman

David Goltzman

McGill University

Publications: 34

Roger J. Hajjar

Roger J. Hajjar

Icahn School of Medicine at Mount Sinai

Publications: 31

Thomas J. Gardella

Thomas J. Gardella

Harvard University

Publications: 30

Something went wrong. Please try again later.